here's my guess on the CT order filing. It seems it is some kind of contract, with a 10 year term, till 2025. Teh contract with Lee's was done 3 years ago, so not them. The contracts with G Tree are also done. I doubt they are changed. If I had to guess? It might be something contractually with Henry Ford relating to heart and neuro. RGRX received the patent for that, but it is henry ford & Dr. Chopp who will most likely be applying for an NIH trial grant $$, and a small trial would surely then be done by Henry Ford & Dr. Chopp. I suppose it makes sense that Henry ford get's something for their work (a royalty or milestone cut?), especially if they succeed in getting NIH $$ (or elsewhere) trial funding for the first small one. BUT, RGRX has to do this as a CT order, because it is unknown yet if any grants will be approved., so it is kept confidential? If the NIH grants Henry ford $$$.we will know around Sept/Oct...when NIH releases who get's grants..., then RGRX could disclose the agreement (??) with them..but they really can't disclose anything yet...until RGRX knows if any grant money does come. MAkes sense.
The fact that there is an expring timeline on tis filing...it probably is some contractual thing.with a fixed 10 year life to 2015. Sems to me most contracts that RGRX enters in to at this stage is material information..but they hide it.
Arghh.Who turned the lights on! the cockroaches came out!
You are one smart cookie, or at least you think so. YUP! RGRX went from 15 cents to the high 50 cent range. Absolute fact.
On JANUARY 30, RGRX was at 15 cents a share. On MAY 5 RGRX closed at 57 cents a share. So that is a 42 cent move? is that the supposed PUMP? if so, let's look for the dump side. from MAY 5 to now.....JUNE 12...RGRX goes from 57 cents to 33 cents. Yup, a fact.
But there is just one teenie weenie problem. Between JANUARY 30 and MAY 5....RGRX traded 10,591,695 shares. That is the pump? 10.5 MILLION SHARES WORTH? But if a pump, the dump always comes after? Hum......I see today that 19,000 shares have traded......that's it.....19,000....if the pumpers bought 10.59 million on the pump, I woudl expect a large amount to now be dumped. Unfortunately.........19,000 shares doesn't qualigy against the 10.59 million.
Nice try though.
B7...quote, ".I wait on news."
You will have a long wait I'm afraid. Lee's is not talking anything of the endless delay for China eye trial.and it is three years after we signed a "partner" deal. You hoped for conference news? the conferences RGRX paid to get into are all but worthless. We are down about 18 cents since he "presented" at such. Abstracts, no matter what.are worthless. There are hundreds of them on TB 4. what good are they? they all are just pre clinical.
Maybe now you realize that there is only ONE bit of news that will help. getting a trial..ANY trial..started. Lee's is not talking and seemingly stalling. G Tree is not talking. RGRX is not talking..Finkel is just saying he does not "know".and that he "hopes" by end of year. Seems to me? if I was CEO? I woudl be in a helluva lot more contact with Lee's and G Tree...so I could say something about how planning progresses. Basically? Finkel is Sargant Shutlz from the TV show 'Hogan's Hero's"......." I know NOTHING." That's why RGRX is where it is....
We will not know if NITE is shorting until teh daily FINRA runs come out. It could be a long seller. The trades you see on teh screen don't adverise if they are long or short sellers. But I'd guess that we'll see 20,000 to 30,000 shorted today. but who knows till the figures come out.
Not all true. It is GGtree's first foray into an actual drug, but G tree did hire an experienced pharma exec as co-ceo........and supposedly this guy pulled in a few other seasoned people..probably as consulting stuff for now. Hyandai Securities is a big firm. The had to have met and sat down w/ mgmt. G Tree surprised me, I will admit. Wasn't expecting either the good hire, swift and easy fundraising (inclding FREE $7 million from gov't).....nor did I expect then to get a $375 million market cap in just a few months.
Yup! RGRX has wasted 20-25 years and "raised"..no, "blown" thru about $100 million..with very little to show for it except a now $35 million TOTAl value market cap. humm...20 years, spend $100 million..get $35 million market cap.
G Tree raises $26 million and in a matter of months get's a $375 million market cap.
rac.....I think the $26 million raised by G tree will go pretty far. The Eye NK phs 3 is Orphan Status...it won't have that many pts. And I don't think the dry eye they hope to do will be over 100 puts. I think they'll get by on $26 million. And I think Ora will do all they can to keep G Tree pleased.......cuz' Ora Inc is the win-win here. No matter what happens in trials, win or lose.Ora Inc get's paid VERY handsomely! And I bet Ora get's paid a whole bunch of $$ UP FRONT. Ora won't get too greedy. they want to keep G Tree as a customer.
We have every right to be vart angry. RGRX hides things all the time. Just like they hide teh real % figures of what we own in the JV with G Tree. Yes, it was an innovative idea. Yes, it benefitted us. but NO we don't know how our % interest goes, except that it get's reduced at some points. BUT BY HOW MUCH??
The Eye Nk trial is very interesting. But I don't see that for a while out. It is a phase 3 and will have to go thru a lot of stuff between Ora, G Tree, RGRx and FDA. I do not believe Ora has done an Eye NK trial before. not that they cannot, it is just they do not have a previously done 'TEMPLATE" (like all their dry eye trials) to offer the FDA of trial design, protocols and endpoints. It is all from scratch..so I bet the eye NK is a ways off.because Ora and Gtree will do it right.....unlike every other trial Finkel has done.
Still doesn't answer the VACUUM of info on China trial and why it is OVER three years since that Lee's partner deal. there is only SO LONG we can buy the "China red tape" excuse, befope people start wondering is Lee's is even interested. If they are? WHY CAN'T THEY JUST SAY THAT RED TAPE CONTINUES and they hope final trial approval soon. Instead, their IR dept ignores queries to them. Which means they don't want to talk about it.
I see G Gtee continued it's fabulous ascent..up 280.....to like 14,850. It must be close to a $375 million market cap? RGRX now $39 million total value. Ratio is now about that it takes 8 shares of RGRX to equal one share of G Tree. And G Tree only is an "arm & a leg" of TB 4 assets. RGRX has the whole cow, Chalk it up to yet another 'Finkelstein Fiasco". It's a very simple reason why no one looks, cares or owns RGRX in USA......basically, NO ONE trusts RGRX or Finkelstein to do anythong right. 20-25 years of flopped, badly designed , poorly executed and some just plain bad luck (Ora trial). It is why I keep saying..NO ONE WILL TOUCH OR LOOK AT RGRX, EVER.....UNTIL THEY SHOW A CLEAR TRIAL WIN. So? the sooner that trial starts, sooner we find out. But yet another "Finkelstein Fiasco" seems brewing in the significant delays Lee's has in China. It's been THREE years since..all that great China stuff was hyped as a "partner". Nothing since. Worse? no updates. We (I) have been INCREDIBLY PATIENT on China, because it isn't easy over there with gov't red tape. But enough is enough....and now we feel like CHUMPS,.....AGAIN? Lee's investor relations person would not reply to inquiry.....and neither did Finkel Tinkel.
ALL G Tree had to do was take RGRX's OLD DATA from first Ora trial...get a COMPETANT CEO.........and then just repeat the data, and Korean investors clamor to own it. USA investors clamor to reun as fast as possible away from Finkel and RGRX.......and RGRX PAYS to get into pannt stock conferences....and after two, we go DOWN! I woudl take a stock swapo deal with G Tree in two seconds.........even if a no premium "merger of equals"/ JUST GET ME THE F away from RGRX mgmt....and into G Tree. All we need is an ADR setup. BUY TEHE COW, G Tree...YOU ALREADY OWN 20%. You will NOT need a premium to do stock swap. WE JUST WANT OUT OF RGRX MGMT and in to G Tree's!
Why bother. If you have no\t figured it out yet, Finkel is worthless, basically. He won't answer. Even if he does he will tell you nothing...all he does is tap dance.
In the meantime, the management at G Tree has done a marvelous job explaining TB 4 (they surpr\ised me).....to the point even analysts at LARGE firms there talk of TB 4 in glowing terms. But all the data they swoon over..TB 4 is the next big thing.....is all same old data from RGRX. With Finkelstein at the helm, we get a $39 million TOTAL value. With G Tree person, they get a moonshot $300 million value. Same exact drug...and RGRX controls far more rights and royalty for it than G Tree does.
Email Finkel Tinkel if you want Worthless waste. Finkel is only at RGRX because his wife is Dr. Goldsteins cousin....ALL Thymosins are Goldsteins baby......all in the family...
The China trial is very important here, because I don't think the US trials will be starting anytime soon. A trial win is what will get RGRX going. Koreans buy the HYPE of G Tree...USA investors RUN AWAY from Fnkel and RGRX....we are now a $39 million market cap compared to G Tree $300 million.
it is a legitimate question to ask. WHAT is going in in China trial? The deal was signed with Lee's THREE YEARS AGO. Chinese gave prelim okay on the trial filing ONE YEAR AGO. We have a right to know. What scared me was that a poster here emailed Lee's and they did NOT respond. He then emaild Finkelstein , and he DID NOT RESPOND. Usually all of investors relation types have a spin answer for you that tells you really nothing. But it was the fact that neither Lee's investor relations or Finkelstein........would answer a query about the China trial. So when I add that up...and three years wait...and over ones years delay since initial trialokay........then we all have every right to wonder what is going on. When Lee's refuses to answer, even with a "stock answer" reply.......there is a reason they don't.
I am starting to wonder if something else is wrong in China. Lee's signed the deal for TB 4 in 2012....3 years ago. In June 2014, the Chinese gov't acdeted the filing for a dry eye trial.. But since then it has been another full year and no final "go ahead".....at least that we know of. PubMed now publishes many China trials on their database.
I'm not trying to sound negative...but it's been long enough now and something does not smell right there. you can see on Lee's website they are initiating trials with other drugs...seemingly on time... And someone here emailed Lee's and they did NOt answer and same with Finkel tinkle. not good.
Isn't that hilarious. Hyundai Securies is a fairly well known firm there. Part of a very big conglomerate. All they did was take the data from what RGRX already disclosed over here, and they write it up.....same data...and it is worth $300 million.
What this goes to show......no, prove....is that bio investors and Wall Street tired very much so of the 20 plus years of RGRX mgmt doing same old screw ups...no one cares. no one will dig into data anymore. Once burned, twice learned.....over here. No one believes Finkel after 20 years of flogging TB 4. We have to PAY to get into a conference thing, and after thgat WE GO DOWN!
if I was G Tree president and I see G Tree stock like this? for the same money to buy 1 share G Tree..you can buy 7.5 shares RGRX.......THE WHOLE COW of RGRX is ridicuoulsy priced, in comparison to G Tree. I guess Hyundai isn't bright enough to highlight that. Otherwise? RGRX would be WELL OVER $1.00 immediately.
OKay.... G Tree market cap is just under $300 million. RGRX market cap is just over $40 million.RGRX owns a lot more TB 4 assets than G Tree does. G Tree is exploding. For the dollar value of G Tree? You could buy 7.5 shares of RGRX for every ONE share of G Tree. Personally? I woudl be in favor of a stock swap into G Tree...but it woudl have to be USA traceable. At least we'd get new mgmt that is competant and get rid of Finkel and his 20-25 years of nothingness. I'd take G Tree shares in a heartbeat..G Tree already owns almost 20% of RGRX...and their stock is now valued 7.5 to 1 of RGRX. But the only reason G Tree is at $300 million is TB 4! Now that G Tree is 7.5 to one ratio.....and G Tree owns 20% of RGRX.a stock swap even with a premium to RGRX..woudl give G Tree ALL the JV deal back, Plus G Tree get's all heart, all near and ALl of Europe for eyes and G Tree woudl get royalty cut from whatever China does. I'd be in favor of a stock swap. But probably never happen.
G Tree 1 to 7.5 RGRX is insane.
Something just is not going right with Lee's in china. They are not talking. Finkel Tinkel won't talk about it either it seems. but it seems liek G Tree in Korea is talking and shouting to the WHOLE Korean investment community, so they get a $250 million market cap, even though they only control a slice of TB 4 or area. RGRX controls far more. Like all Europe for eyes and heart and neuro......If Finkel dope followed G tree and RGRX get's a $250 million market cap, RGRX woudl be at $2.50 today..instead we sink and G Tree explodes. G Tree is there BECAUSE of TB 4, RGrX just does nothing..
I've been patient on China. but the fact there is conscious avoidance by Lee's and RGRX to mention it or give an update.....signals to me something is not right. Something never goes right with Finkel..... and trials........ever.
You wish the PR team to care about teh long term and not day to day? Check the filings. The PR firm was hired for 6 months only...180 days. And it started in April. So they are finished by around end of September. We "paid" them to get RGRX into two conferences.....and Iknew these types of "pay to present" conferences don't usually produce much serious investor interest after. RGRX is actully down in price from before the two conferences.. Abstracts won't move us either. what will move RGRX is a trial starting.. the sooner a trial starts, the sooner we see if we have a trial win. At this point.after 25 years of mishaps....the only thing to get RGRX share price to where your dreams are.... is a TRIAL WIN! Where is the China trial??? I don't expect any US trial by Ora until very late 2015 and ear;y 2016. So China is it for now.
I think RGRX is paying the 'PR" team $30,000....probably some of that was used to get RGRX into these two small conferences. You "pay to play"..i.e......we had to pay tio be able to get in, and teh PR firm handled that. The PR firm probably works on some kind or release, but they wait till real news they can run with. A new abstract isn't going to do it. But starting the China trial woudl be news they can run with.
This is interesting. I just checked website "clinical trials(dot)gov to see if any thing listed new for TB 4. Go to site. I just typed in thymosin. responses showed that clinicaltrials(dot)gov also shows all Thymosin trials (TA-1) that are being done in CHINA. Go look. So this means that I assume when Lee's get's final approval for their TB 4 dry eye China, it will also show up on the site so we can know all the trial info? It is a real help if we can acces the FDA site to see the China trial design. but what we don't know is why the hold up. It has ben a year since preliminary "go". Is it Lee's or gov't that stalls??
To create the kind of action as seen in G Tree, it's pretty clear that G Tree is talking more to investors over there. It is pure momentum. I think what coudl be driving is that G Tree is saying things go well w/ the US FDA in terms of getting trials designed for FDA review. And Ora is involved. I think the first one to go will be the Eye NK Orphan Phase 3.....being an Orphan status means a smaller pt number and FDA is more flexinble compared to the rigors they force on regular trials. So I think G Tree is probably letting on that things are progressing well with design and Ora and FDA input? who knows. But I think it pretty obvious that G Tree talks more to investors than Finkel does.
OMG, you just don't get it! The average person in China knows that their knockoff quality of any good or drug, isn't as good or safe as western made productss. It is 100% why SCLN still makes money. TA-1 has no patent proteection left in China. There are generic makers of TA-1 in China......but it is still teh WESTERN TA-1 that stays in demand. Furthermore, the largest purchaser of drugs is actually the Chinese gov't for their formulary and the Military and for all politcail officials (they don't use Chinesee made drugs)! they buy WESTERN made drugs, not Chinese knockoffs. RGRX will get no advantage from TB 4 made in China. If Lee's decides to, they will make it in Hong Kong.
Next? You have to be off your rocker if you think that when or IF TB 4 get's USA approval......that G Tree or any other big pharma that coudl but it from G Tree.WILL EVER HAVE IT MADE IN CHINA TO SELL IT IN THE USA...! No way. delusional. never happen. FYI? Our FDA isn't in charge of China mfg inspections and quality control is not good for the most part.. I don't know what donk dope is saying, but don't listen!